Literature DB >> 26067430

Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.

Johannes Goldberg1, Tim Clarner1, Cordian Beyer1, Markus Kipp2,3.   

Abstract

Although multiple sclerosis (MS) has been considered a white matter disease, MS lesions occur frequently in the gray matter parts of the brain. Gray matter demyelination and atrophy are found during earliest disease stages, and a growing body of evidence demonstrates a positive correlation between gray matter pathology and various measures of motor disability and cognitive impairment. The cuprizone model is classically regarded as white matter demyelination model. However, recent evidence suggests that different gray matter areas are also affected. In this study, we address the vulnerability of white and gray matter forebrain regions in the cuprizone model. While the corpus callosum as interhemispheric white matter tract is affected in this model, other white matter tracts such as the mammillo-thalamic tract, the columns of the fornix, the stria terminalis, the optic tract, or hippocampal fimbria do not present overt demyelination after 5-week cuprizone intoxication. In contrast, gray matter demyelination is widespread in this model. Furthermore, vulnerable white matter tracts display extensive acute axonal damage. These results highlight the relevance of the cuprizone model to study MS-related gray matter pathology and neurodegeneration.

Entities:  

Keywords:  Axonal damage; Cuprizone; Demyelination; Gray matter; Microglia; Neurodegeneration; White matter

Mesh:

Substances:

Year:  2015        PMID: 26067430     DOI: 10.1007/s12031-015-0595-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  42 in total

1.  Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice.

Authors:  W F Blakemore
Journal:  J Neurocytol       Date:  1972-12

2.  Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.

Authors:  Thomas Skripuletz; Maren Lindner; Alexandra Kotsiari; Niklas Garde; Jantje Fokuhl; Franziska Linsmeier; Corinna Trebst; Martin Stangel
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

Review 3.  The cuprizone animal model: new insights into an old story.

Authors:  Markus Kipp; Tim Clarner; Jon Dang; Sjef Copray; Cordian Beyer
Journal:  Acta Neuropathol       Date:  2009-09-18       Impact factor: 17.088

4.  Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL/6 mice.

Authors:  Katrin Hoffmann; Maren Lindner; Ina Gröticke; Martin Stangel; Wolfgang Löscher
Journal:  Exp Neurol       Date:  2007-11-22       Impact factor: 5.330

5.  Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes.

Authors:  L Xiao; H Xu; Y Zhang; Z Wei; J He; W Jiang; X Li; L E Dyck; R M Devon; Y Deng; X M Li
Journal:  Mol Psychiatry       Date:  2007-08-07       Impact factor: 15.992

Review 6.  Cuprizone-induced demyelination as a tool to study remyelination and axonal protection.

Authors:  Adib Zendedel; Cordian Beyer; Markus Kipp
Journal:  J Mol Neurosci       Date:  2013-05-12       Impact factor: 3.444

7.  Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.

Authors:  Akvile Norkute; Andrea Hieble; Alena Braun; Sonja Johann; Tim Clarner; Werner Baumgartner; Cordian Beyer; Markus Kipp
Journal:  J Neurosci Res       Date:  2009-05-01       Impact factor: 4.164

8.  Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia.

Authors:  Hong-Ju Yang; Haitao Wang; Yanbo Zhang; Lan Xiao; Richard W Clough; Ronald Browning; Xin-Min Li; Haiyun Xu
Journal:  Brain Res       Date:  2009-03-21       Impact factor: 3.252

9.  Short-term cuprizone feeding induces selective amino acid deprivation with concomitant activation of an integrated stress response in oligodendrocytes.

Authors:  Johannes Goldberg; Moritz Daniel; Yasemin van Heuvel; Marion Victor; Cordian Beyer; Tim Clarner; Markus Kipp
Journal:  Cell Mol Neurobiol       Date:  2013-08-25       Impact factor: 5.046

Review 10.  Is the risk of multiple sclerosis related to the 'biography' of the immune system?

Authors:  Bernd Krone; Frank Oeffner; John M Grange
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

View more
  32 in total

1.  Integrin-Kindlin3 requirements for microglial motility in vivo are distinct from those for macrophages.

Authors:  Julia Meller; Zhihong Chen; Tejasvi Dudiki; Rebecca M Cull; Rakhilya Murtazina; Saswat K Bal; Elzbieta Pluskota; Samantha Stefl; Edward F Plow; Bruce D Trapp; Tatiana V Byzova
Journal:  JCI Insight       Date:  2017-06-02

2.  Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Stefan Esser; Larissa Göpfrich; Kai Bihler; Eugenia Kress; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Markus Kipp; Lars-Ove Brandenburg
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

3.  Formyl Peptide Receptor 1-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Kai Bihler; Eugenia Kress; Stefan Esser; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Lars-Ove Brandenburg
Journal:  J Mol Neurosci       Date:  2017-05-02       Impact factor: 3.444

4.  Investigation of Cuprizone Inactivation by Temperature.

Authors:  Sandra Heckers; Nadine Held; Jessica Kronenberg; Thomas Skripuletz; Andre Bleich; Viktoria Gudi; Martin Stangel
Journal:  Neurotox Res       Date:  2017-01-26       Impact factor: 3.911

5.  The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model.

Authors:  Laura Salinas Tejedor; Tanja Wostradowski; Stefan Gingele; Thomas Skripuletz; Viktoria Gudi; Martin Stangel
Journal:  J Mol Neurosci       Date:  2017-01-26       Impact factor: 3.444

6.  Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice.

Authors:  Tanja Hochstrasser; Gianna Lisa Exner; Stella Nyamoya; Christoph Schmitz; Markus Kipp
Journal:  J Mol Neurosci       Date:  2017-02-25       Impact factor: 3.444

7.  Nebivolol elicits a neuroprotective effect in the cuprizone model of multiple sclerosis in mice: emphasis on M1/M2 polarization and inhibition of NLRP3 inflammasome activation.

Authors:  Antoinette G Naeem; Reem N El-Naga; Haidy E Michel
Journal:  Inflammopharmacology       Date:  2022-08-10       Impact factor: 5.093

8.  Alpha-lipoic acid mitigates toxic-induced demyelination in the corpus callosum by lessening of oxidative stress and stimulation of polydendrocytes proliferation.

Authors:  Nima Sanadgol; Fereshteh Golab; Hassan Askari; Fatemeh Moradi; Marziyeh Ajdary; Mehdi Mehdizadeh
Journal:  Metab Brain Dis       Date:  2017-10-12       Impact factor: 3.584

9.  Longitudinal evaluation of demyelinated lesions in a multiple sclerosis model using ultrashort echo time magnetization transfer (UTE-MT) imaging.

Authors:  Caroline Guglielmetti; Tanguy Boucneau; Peng Cao; Annemie Van der Linden; Peder E Z Larson; Myriam M Chaumeil
Journal:  Neuroimage       Date:  2019-12-04       Impact factor: 6.556

10.  Metformin Therapy Attenuates Pro-inflammatory Microglia by Inhibiting NF-κB in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis.

Authors:  Mahdad Abdi; Parichehr Pasbakhsh; Maryam Shabani; Saied Nekoonam; Asie Sadeghi; Fardin Fathi; Morteza Abouzaripour; Wael Mohamed; Kazem Zibara; Iraj Ragerdi Kashani; Adib Zendedel
Journal:  Neurotox Res       Date:  2021-09-27       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.